The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a...read more
Fulgent Genetics, which offers genetic testing for over 7,500 conditions, raised $38 million by offering 4.2 million shares at $9, the low end of the range of $9 to $11. Fulgent originally planned to raise $60 million by offering 4.6 million shares at $12 to $14...read more
Fulgent Genetics, which offers genetic testing for over 7,500 conditions, lowered the proposed deal size for its upcoming IPO on Wednesday. The Temple City, CA-based company now plans to raise $42 million by offering 4.2 million shares at a price range of...read more
Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the...read more
US IPO Weekly Recap: Nutanix skyrockets 131% in year's best IPO debut
The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a...read more
Fulgent Genetics prices IPO at $9, the low end of the downwardly revised range
Fulgent Genetics, which offers genetic testing for over 7,500 conditions, raised $38 million by offering 4.2 million shares at $9, the low end of the range of $9 to $11. Fulgent originally planned to raise $60 million by offering 4.6 million shares at $12 to $14...read more
Fulgent Genetics decreases proposed IPO deal size
Fulgent Genetics, which offers genetic testing for over 7,500 conditions, lowered the proposed deal size for its upcoming IPO on Wednesday. The Temple City, CA-based company now plans to raise $42 million by offering 4.2 million shares at a price range of...read more
US IPO Week Ahead: Year's largest US tech company to IPO, Nutanix, leads 5-deal week
Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the...read more